Subscribe to RSS
DOI: 10.1055/s-2008-1038224
Erstdiagnose Epilepsie – Wie ist das medikamentöse Vorgehen?
Therapeutic Management Following Diagnosis of EpilepsyPublication History
Publication Date:
05 November 2008 (online)

Lernziele
Die Planung und Gestaltung einer medikamentösen Therapie nach der Diagnose einer Epilepsie öffnet vielfältige Optionen, die sich aus der relativen Vielfalt der verfügbaren Antiepileptika (AED) ergibt. Dargestellt werden Argumente zum Therapiebeginn (erhöhtes Rezidivrisiko) sowie die Auswahl der AED, die sich am Epilepsietyp orientiert (idiopathische Epilepsien mit generalisierten Anfällen versus symptomatische oder kryptogene Epilepsien mit fokalen und sekundär generalisierten Anfällen) und mögliche negative Effekte der AED auf kognitive, endokrine oder psychische Funktionen sowie die Teratogenität berücksichtigt. Damit eröffnet sich die Chance mit einem der ersten beiden AED in Monotherapie eine individuell günstige Therapie zu etablieren, die dauerhaft eine möglichst optimale Behandlung des Patienten ermöglicht.
Literatur
- 1
Bauer J.
Seizure inducing effects of antiepileptic drugs.
Acta Neurol Scand.
1996;
94
367-377
Reference Ris Wihthout Link
- 2
Kwan P, Brodie M J.
Early identification of refractory epilepsy.
N Engl J Med.
2000;
342
314-319
Reference Ris Wihthout Link
- 3 Dulac O, Leppik I E, Chadwick D W. et al .Starting and stopping treatment. In: Engel J Jr, Pedley TA, eds. Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1301-1309
Reference Ris Wihthout Link
- 4 Second European Working Group on Epilepsy and Driving .Epilepsy and Driving. April, 3, 2005 (Handout of final report)
Reference Ris Wihthout Link
- 5
Gilad R, Lampl Y, Gabbay U. et al .
Early treatment of single generalized tonic-clonic seizure to prevent recurrence.
Arch Neurol.
1996;
53
1149-1152
Reference Ris Wihthout Link
- 6
First seizure trial group .
Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk
of relapse after a first unprovoked tonic-clonic seizure.
Neurology.
1993;
43
478-483
Reference Ris Wihthout Link
- 7
Mattson R H, Cramer J A, Collins J F. et al .
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and
secondarily generalized tonic-clonic seizures.
N Engl J Med.
1985;
313
145-151
Reference Ris Wihthout Link
- 8 Beghi E, Berg A T, Shinnar S. et al .Treatment of single and infrequent seizures. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1327-1333
Reference Ris Wihthout Link
- 9
Musicco M, Beghi E, Solari A. et al .
Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy.
Neurology.
1997;
49
991-998
Reference Ris Wihthout Link
- 10
Marson A, Jacoby A, Johnson A. et al .
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single
seizures: a randomised controlled trial.
Lancet.
2005;
365
2007-2013
Reference Ris Wihthout Link
- 11
Camfield P, Camfield C, Smith S. et al .
Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure:
a 15-year follow-up from a randomized trial in childhood.
Epilepsia.
2002;
43
662-663
Reference Ris Wihthout Link
- 12
Bös M, Bauer J.
Wirbelkörperkompression durch epileptische Anfälle.
Nervenheilkunde.
2007;
26
421-423
Reference Ris Wihthout Link
- 13
Pick L, Bauer J.
Zahnmedizin und Epilepsie.
Nervenarzt.
2001;
72
946-949
Reference Ris Wihthout Link
- 14
Guberman A.
Seizure-related injuries and death in adult epilepsy.
Can J Neurol Sci.
1990;
17
256
Reference Ris Wihthout Link
- 15 Nashef L, Tomson T. Sudden death in epilepsy. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1991-1998
Reference Ris Wihthout Link
- 16 Hirsch L J, Pedley T A. Goals of therapy. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1125-1128
Reference Ris Wihthout Link
- 17
Kowalik A, Bauer J, Elger C E.
Asystole Anfälle.
Nervenarzt.
1998;
69
151-157
Reference Ris Wihthout Link
- 18 Bauer J. Diagnose des Status epilepticus. In: Fröscher W, Vassella F, Hufnagel A (Hrsg). Die Epilepsien. Stuttgart: Schattauer 2004: 235-243
Reference Ris Wihthout Link
- 19
Marson A G, Al-Kharusi A M, Alwaidh M. et al .
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine
or topiramate for partial epilepsy for treatment of partial epilepsy: an unblinded
randomised controlled trial.
Lancet.
2007;
369
1000-1015
Reference Ris Wihthout Link
- 20
Marson A G, Al-Kharusi A M, Alwaidh M. et al .
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised
and unclassifiable epilepsy: an unblinded randomised controlled trial.
Lancet.
2007;
369
1016-1026
Reference Ris Wihthout Link
- 21
Bauer J, Buchmüller L, Reuber M. et al .
Which patients become seizure free with antiepileptic drugs. An observational study
in 821 patients.
Acta Neurol Scand.
2008;
117
55-59
Reference Ris Wihthout Link
- 22 Wasterlain C G, Treiman D M. Status epilepticus. Cambrige: MIT Press 2006
Reference Ris Wihthout Link
- 23
Bauer J, Elger C E.
Management of status epilepticus in adults.
CNS Drugs.
1994;
1
26-44
Reference Ris Wihthout Link
- 24
Beyenburg S, Bauer J, Elger C E.
Therapie des generalisierten tonisch-klonischen Status epilepticus im Erwachsenenalter.
Nervenarzt.
2000;
71
65-77
Reference Ris Wihthout Link
- 25
Bauer J.
Epilepsietherapie im Erwachsenenalter.
Nervenarzt.
2007;
78 (Suppl 1)
27-35
Reference Ris Wihthout Link
- 26 Patsalos P N, Berry D J, Bourgeois B F. et al .Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: A position
paper by the subcommision on therapeutic drug monitoring, ILAE Commission on the Therapeutic
Strategies. Epilepsia 2008; epub ahead of print. Online im Internet: http://www.blackwell-synergy.com/doi/abs/10.111/j.1528–1167.2008.01561.x
Reference Ris Wihthout Link
- 27 Johannessen S I, Patsalos P N, Tomson T. et al .Therapeutic drug monitoring. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1171-1183
Reference Ris Wihthout Link
- 28
Rowan A J, Ramsay R E, Collins J F. et al .
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.
Neurology.
2005;
64
1868-1873
Reference Ris Wihthout Link
- 29
Morrow J, Russell A, Guthrie E. et al .
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the
UK Epilepsy and Pregnancy Register.
J Neurol Neurosurg Psychiatry.
2006;
77
193-198
Reference Ris Wihthout Link
- 30
Cunnington M, Ferber S, Quartey G. et al .
Effect of dose on the frequency of major birth defects following fetal exposure to
lamotrigine monotherapy in an International Observational Study.
Epilepsia.
2007;
48
1207-1210
Reference Ris Wihthout Link
- 31
Montouris G.
Safety of the newer antiepileptic drug oxcarbazepine during pregnancy.
Curr Med Res Opin.
2005;
21
693-701
Reference Ris Wihthout Link
- 32
Holmes L B, Wyszynski D F, Liebermann E.
The AED (antiepileptic drug) pregnancy registry: a 6-year experience.
Arch Neurol.
2004;
61
673-678
Reference Ris Wihthout Link
- 33
Rück J, Bauer J.
Schwangerschaftsberatung und Epilepsie. Eine retrospektive Analyse bei 118 Frauen.
Nervenarzt.
2008;
79
691-695
Reference Ris Wihthout Link
- 34
Bauer J, Isojärvi J IT, Herzog A G. et al .
Reproductive dysfunction in women with epilepsy: recommendations for evaluation and
management.
J Neurol Neurosurg Psychiatry.
2002;
73
121-125
Reference Ris Wihthout Link
- 35
Bauer J, Cooper-Mahkorn D.
Reproductive dysfunction in women with epilepsy: Menstrual cycle abnormalities, fertility
and polycystic ovary syndrome.
Int Rev Neurobiol.
2008 [in press];
Reference Ris Wihthout Link
- 36 Bauer J, Klingmüller D, Rösing B. Wozu Endokrinologie in der Epileptologie? 2. Aufl. Nürnberg: Novartis 2006
Reference Ris Wihthout Link
- 37
Herzog A G, Drislane F W, Schomer D L. et al .
Differential effects of antiepileptic drugs on sexual function and hormones in men
with epilepsy.
Neurology.
2005;
65
1016-1020
Reference Ris Wihthout Link
- 38
Bauer J, Blumenthal S, Reuber M. et al .
Epilepsy syndrome, focus location, and treatment affect testicular function in men
with epilepsy.
Neurology.
2004;
62
243-246
Reference Ris Wihthout Link
- 39
Kwan P, Brodie M J.
Neuropsychological effects of epilepsy and antiepileptic drugs.
Lancet.
2001;
357
216-222
Reference Ris Wihthout Link
- 40
Kühn K U, Quednow B B, Thiel M. et al .
Antidepressive treatment in patients with temporal lobe epilepsy and major depression:
a prospective study with three different antidepressants.
Epilepsy Behav.
2003;
4
674-679
Reference Ris Wihthout Link
- 41
Bauer J.
Epilepsiepatienten in der Hausarztpraxis.
MMW.
2008;
150 (Sonderheft 2)
2-5
Reference Ris Wihthout Link
- 42
Sharpe C, Buchanan N.
Juvenile myoclonic epilepsy: diagnosis, management and outcome.
Med J Aust.
1995;
162
133-134
Reference Ris Wihthout Link
- 43
Bauer J, Saher M S, Burr W. et al .
Precipitating factors and therapeutic outcome in epilepsy with generalized tonic-clonic
seizures.
Acta Neurol Scand.
2000;
102
205-208
Reference Ris Wihthout Link
- 44
Berges S, Moulin T, Berger E. et al .
Seizures and epilepsy following stroke: recurrence factors.
Eur Neurol.
2000;
43
3-8
Reference Ris Wihthout Link
- 45
Ferro J M, Canhao P, Bousser M G. et al .
Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role
of antiepileptics.
Stroke.
2008;
39
1152-1158
Reference Ris Wihthout Link
- 46
Brodie M J, Overstall P W, Giorgi L.
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine
in elderly patients with newly diagnosed epilepsy.
Epilepsy Res.
1999;
37
81-87
Reference Ris Wihthout Link
- 47
Lieu A S, Hwong S L.
Intracranial meningeomas and epilepsy: incidence, prognosis and influencing factors.
Epilepsy Res.
2000;
38
45-52
Reference Ris Wihthout Link
- 48 Langendorf F G, Pedley T A, Temkin N R. Posttraumatic seizures. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 2537-2542
Reference Ris Wihthout Link
- 49
Haltiner A M, Temkin N R, Dikmen S S.
Risk of seizure recurrence after the first late posttraumatic seizure.
Arch Phys Med Rehabil.
1997;
78
835-840
Reference Ris Wihthout Link
- 50
Bös M, Bauer J.
Epilepsien durch Schussverletzungen.
Aktuel Neurol.
2007;
34
559-563
Reference Ris Wihthout Link
- 51 Bauer J. Fahreignung bei Epilepsie. In: Madea B, Musshoff F, Berghaus G (Hrsg). Verkehrsmedizin. Köln: Deutscher Ärzteverlag 2007: 381-394
Reference Ris Wihthout Link
- 52
Medical Research Council Antiepileptic Drug Withdrawal Study Group .
Randomised study of antiepileptic drug withdrawal in patients in remission.
Lancet.
1991;
337 (8751)
1175-1180
Reference Ris Wihthout Link
- 53
French J A, Kanner A M, Bautista J. et al .
Efficacy and tolerabilty of the new antiepileptic drugs, I: Treatment of new-onset
epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology
and the American Epilepsy Society.
Epilepsia.
2004;
45
401-409
Reference Ris Wihthout Link
- 54
Bauer J, Bös M.
Treatment strategies for focal epilepsy.
Expert Opin Pharmacother.
2008 [in press];
Reference Ris Wihthout Link
- 55 Dodson W E, Brodie M J. Efficacy of antiepileptic drugs. In: Engel J Jr, Pedley TA (eds). Epilepsy: A comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins 2008: 1185-1192
Reference Ris Wihthout Link
Prof. Dr. Jürgen Bauer
Klinik für Epileptologie, Universitätsklinikum Bonn
Sigmund Freud Straße 25
53105 Bonn
Email: juergen.bauer@ukb.uni-bonn.de